Literature DB >> 32707238

Five-year follow-up of early intervention peanut oral immunotherapy.

Lauren Herlihy1, Edwin H Kim2, A Wesley Burks2, Holly Barber2, Quindelyn Cook3, Luanna Yang4, Deanna Hamilton2, Brian P Vickery5.   

Abstract

Entities:  

Year:  2020        PMID： 32707238     DOI： 10.1016/j.jaip.2020.07.009

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  3 in total

1.  Weighing the benefits and risks of oral immunotherapy in clinical practice.

Authors:  Aikaterini Anagnostou
Journal:  Allergy Asthma Proc       Date:  2021-03-01       Impact factor: 2.587

Review 2.  A Practical, Stepwise Approach to Peanut Oral Immunotherapy in Clinical Practice: Benefits and Risks.

Authors:  Aikaterini Anagnostou
Journal:  J Asthma Allergy       Date:  2021-03-25

Review 3.  Latest Developments in the Management of Nut Allergies.

Authors:  H A Brough; R Gourgey; S Radulovic; J C Caubet; G Lack; A Anagnostou
Journal:  Curr Treat Options Allergy       Date:  2021-06-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.